Clinical trial Recruiting at 1 site Observational Ages 18 to 67

Metabolic and infectious diseases in La Réunion

Official title: Pathologies métaboliques et Infectieuses en Population générale à La Réunion : étude REUNION

Run by Institut National de la Santé Et de la Recherche Médicale, France · NCT05400824 · Data updated 2026-11-12

Researchers are testing how common metabolic and infectious diseases are in La Réunion and what factors like microbiota and genetics might influence them, by examining 2,000 adults over two years.

Quick facts

Study typeObservational
Ages18 Years to 67 Years
SexAll
Enrollment2000 (estimated)
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
Government
Locations1 site (La Réunion, Saint-Pierre)
StatusRecruiting
StartedMay 1, 2022
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedJuly 10, 2026
Trial IDNCT05400824 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–67 in La Réunion who consent to genetic analysis and participate in the full assessment protocol.

Probably not a fit

Individuals who do not participate in genetic analysis or decline some study procedures may not experience direct personal benefit from the research.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will recruit 2,000 men and women aged 18–67 in La Réunion over two years to undergo comprehensive clinical assessments. Participants will provide blood, DNA, hair, and fecal samples, complete cognitive tests, and have evaluations of autonomic function, spirometry, pulse wave velocity, and carotid Doppler tracking. Additional data on social factors and genetics will be collected to explore risk factors and prevalence of cardiometabolic and infectious conditions. The study aims to map how microbiota, cognitive function, social inequalities, and genetics relate to disease patterns in this population.

Why it matters

Potential benefit: If successful, the study could improve understanding of disease prevalence and contributing factors, guiding future prevention and public health strategies for the local population.

How similar studies have gone: Similar population-based assessments have yielded valuable epidemiological insights, though detailed links to microbiota and genetics remain an evolving area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18-67 years
* given consent for genetic analysis,
* written consent for participating in the study

Exclusion Criteria:

* judicial protection or guardianship

Where it's running

  • Centre Hospitalier Universitaire de La Réunion
    La Réunion, Saint-Pierre, France
    Recruiting

Study contacts

  • Principal investigator: Maxime COURNOT, MD, PhD — Institut National de la Santé Et de la Recherche Médicale, France
  • Study coordinator: Maxime COURNOT
  • Email: maxime.cournot@inserm.fr
  • Phone: +262262938811

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.